Hanson & Doremus Investment Management’s Labcorp LH Stock Holding History

Hanson & Doremus Investment Management’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$179K	Hold	672	–	–	0.02%	205
2025 Q4	$169K	Hold	672	–	–	0.02%	209
2025 Q3	$193K	Sell	672 -50	-7%	-$13.4K	0.02%	205
2025 Q2	$190K	Buy	722 +65	+10%	+$15.8K	0.03%	202
2025 Q1	$153K	Hold	657	–	–	0.02%	206
2024 Q4	$151K	Buy	657 +32	+5%	+$7.34K	0.02%	209
2024 Q3	$140K	Sell	625 -45	-7%	-$9.89K	0.02%	209
2024 Q2	$136K	Hold	670	–	–	0.02%	205
2024 Q1	$146K	Hold	670	–	–	0.03%	203
2023 Q4	$152K	Hold	670	–	–	0.03%	201
2023 Q3	$135K	Sell	670 -259	-28%	-$54.6K	0.03%	203
2023 Q2	$193K	Sell	929 -42	-4%	-$8.15K	0.04%	178
2023 Q1	$191K	Sell	971 -339	-26%	-$69.8K	0.04%	179
2022 Q4	$265K	Buy	1,310 +52	+4%	+$10.2K	0.06%	159
2022 Q3	$221K	Buy	1,258 +243	+24%	+$49.7K	0.06%	167
2022 Q2	$204K	Hold	1,015	–	–	0.05%	181
2022 Q1	$230K	Sell	1,015 -13	-1%	-$3.06K	0.05%	178
2021 Q4	$277K	Hold	1,028	–	–	0.06%	162
2021 Q3	$249K	Sell	1,028 -124	-11%	-$31.3K	0.06%	156
2021 Q2	$186K	Sell	1,152 -162	-12%	-$36.9K	0.06%	166
2021 Q1	$288K	Buy	1,314 +157	+14%	+$31.5K	0.07%	154
2020 Q4	$202K	Buy	1,157 +5	+0.4%	+$864	0.05%	175
2020 Q3	$186K	Buy	1,152 +73	+7%	+$11.6K	0.06%	166
2020 Q2	$154K	Buy	1,079 +55	+5%	+$7.61K	0.05%	173
2020 Q1	$111K	Sell	1,024 -216	-17%	-$31.1K	0.04%	200
2019 Q4	$180K	Hold	1,240	–	–	0.05%	179
2019 Q3	$179K	Buy	1,240 +139	+13%	+$20.3K	0.06%	180
2019 Q2	$164K	Buy	1,101 +276	+33%	+$38.5K	0.05%	192
2019 Q1	$108K	Buy	825 +714	+643%	+$88K	0.04%	214
2018 Q4	$12K	Hold	111	–	–	﹤0.01%	378
2018 Q3	$16K	Hold	111	–	–	0.01%	377
2018 Q2	$17K	Sell	111 -139	-56%	-$21K	0.01%	391
2018 Q1	$35K	Buy	250 +139	+125%	+$20.4K	0.01%	344
2017 Q4	$15K	Sell	111 -14	-11%	-$1.85K	0.01%	412
2017 Q3	$16K	Hold	125	–	–	0.01%	390
2017 Q2	$16K	Sell	125 -27	-18%	-$3.31K	0.01%	388
2017 Q1	$19K	Hold	152	–	–	0.01%	360
2016 Q4	$16.8K	Hold	152	–	–	0.01%	343
2016 Q3	$18K	Sell	152 -16	-10%	-$1.89K	0.01%	331
2016 Q2	$19K	Hold	168	–	–	0.01%	313
2016 Q1	$17K	Sell	168 -156	-48%	-$15K	0.01%	334
2015 Q4	$34K	Hold	324	–	–	0.02%	292
2015 Q3	$30K	Hold	324	–	–	0.01%	291
2015 Q2	$34K	Sell	324 -466	-59%	-$48.5K	0.01%	288
2015 Q1	$86K	Buy	+790	New	+$81.2K	0.04%	218

Other funds holding LH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Hanson & Doremus Investment Management's LH Position: Q1 2026 in Review

Hanson & Doremus Investment Management held its Labcorp (LH) position steady in Q1 2026 at 672 shares worth $179K. The position accounts for 0.02% of the portfolio, ranked #205.

Hanson & Doremus Investment Management first reported a position in LH in Q1 2015 and has held it in 45 quarters since. The position peaked at $288K in Q1 2021. 1,031 funds tracked by Wall St. Rank hold LH as of Q1 2026.

Hanson & Doremus Investment Management held 672 shares of Labcorp worth $179K as of Q1 2026.
Hanson & Doremus Investment Management left its Labcorp share count unchanged in Q1 2026.
Labcorp made up 0.02% of Hanson & Doremus Investment Management's portfolio in Q1 2026, its #205 holding.
Hanson & Doremus Investment Management first reported a position in Labcorp in Q1 2015 and has held it in 45 quarters since.
Hanson & Doremus Investment Management's Labcorp position peaked at $288K in Q1 2021.
1,031 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.

Based on Hanson & Doremus Investment Management's 13F filing for Q1 2026, filed 17 Apr 2026.